UT MD Anderson is a global leader in cancer care, research, prevention and education, ranked No. 1 in the nation for cancer care by U.S. News & World Report for the 12th year in a row. Over the past year, the institution saw historic milestones in its mission to end cancer. UT MD Anderson provided care for more than 197,000 patients, reached $7.8 billion in annual revenue, and led the world’s largest cancer clinical trials program, with 30 of 43 cancer drugs approved by the FDA last year investigated at UT MD Anderson. The institution announced a $150 million gift from Kinder Foundation to establish Kinder Children’s Cancer Center, a joint venture of UT MD Anderson and Texas Children’s, also in Houston, with a singular mission of ending childhood cancer. The institution also launched a $2.5 billion philanthropic campaign, “Only Possible Here, The Campaign to End Cancer.” This campaign, the largest in UT MD Anderson’s history, already raised $2.14 billion to support strategic priorities. National and international honors for quality, safety and patient experience include a 5-star Vizient rating for five years in a row, as well as a sixth consecutive Magnet designation and first-ever Magnet with distinction.
